Replies to post #70427 on Biotech Values

[Biowatch]

Anadys Hep C Drug Reduces Virus Levels ANDS

>>Eight patients with hepatitis C treated with a twice-daily dose of the drug ANA598 reported a median reduction of more than 99% in the level of virus after three days of treatment, the company said.<<

http://www.thestreet.com/_yahoo/newsanalysis/biotech/10456660.html


>>ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
Thursday January 8, 7:00 am ET

Patients treated at the initial dose in an ongoing Phase Ib trial demonstrated a 2.5 log10 median viral load decline after three days

Conference Call Today at 8:30AM EST<<
http://biz.yahoo.com/prnews/090108/la56730.html?.v=1